About AventaMed
AventaMed is a Healthcare company based in Cork (Ireland) founded in 2013 by Keith Jansen, John Vaughan, and Olive Odriscoll, and was acquired by Karl Storz in February 2023. Device for safe placement of grommets. AventaMed has raised $3.58 million across 4 funding rounds from investors including Enterprise Ireland, Karl Storz and HBAN. Its chief executive, as recorded, is Keith Jansen. AventaMed offers products and services including Solo+ ™. Its focus areas include Life Sciences, ENT Disorders, Medical Devices and Therapeutic Devices. Its legal entity is AventaMed DAC.
Company details
AventaMed is developing surgical devices, initially focused on a device which allows safe placement of ear tubes or grommets in an out-patient setting. Grommets are used to surgically treat Otitis Media with Effusion, which is a build up of fluid behind the ear drum. Was spun out from the MEDIC research centre, Cork Institute of Technology.
- Headquarters Cork, Ireland
- Founders Keith Jansen, John Vaughan, Olive Odriscoll
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website aventamed.com
- Social LinkedIn X
- Acquired by Karl Storz (Feb 2023)
- Legal Name Aventamed Dac
- Total Equity Funding$3.58M (USD)
in 4 rounds
- Latest Funding Round$2.12M (USD), Angel Round
Oct 2017
- InvestorsEnterprise Ireland
& 3 more
- Acquired byKarl Storz
(Feb 2023)
Products & Services of AventaMed
AventaMed offers a comprehensive portfolio of products and services, including Solo+ ™.
Device for quick ear tube insertion using topical anesthesia.
Funding Insights of AventaMed
AventaMed has successfully raised a total of $3.58M across 4 strategic funding rounds. The most recent funding activity was a Angel Round of $2.12 million completed in October 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.58M
- Total Rounds 4
- Last Round Angel Round — $2.12M
- First Round $123,800
(Nov 2014)
- Investors Count 3
All 4 funding rounds of AventaMed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2017 | $2.12M | Angel Round | – | Halo Business Angel Network | |
| Oct 2015 | $50,000 | Grant | – | – | – |
| Sep 2015 | $1.46M | Seed | – | – | |
| Nov 2014 | $123,800 | Grant | – | – | – |
4 investors in total: 4 institutional.
Investors in AventaMed
AventaMed has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, Karl Storz and HBAN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A platform connecting angel investors to startups in Ireland. | hban.org | Ireland | ||
| irrusinvestments.com | ||||
Support is provided to Irish manufacturing and service sector businesses. | 1998 | enterprise-ireland.com | Dublin, Ireland | |
Endoscopic instruments, devices, and camera systems are developed and manufactured. | 1945 | karlstorz.com | Tuttlingen, Germany |
Investor details for AventaMed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AventaMed
8 people are tracked at AventaMed (3 in leadership, 5 in board & advisors).
| Name | Role | Group |
|---|---|---|
Keith Jansen | Co-Founder & CEO | Leadership |
John Vaughan | Co-Founder | Leadership |
Olive Odriscoll | Co-Founder & CEO | Leadership |
Rick Geoffrion | Chairman & Non-Executive Director | Board & advisors |
Bernard Lim | Non-Executive Director | Board & advisors |
Bruce Clibborn | Board Member | Board & advisors |
Jack Cashman | Non-Executive Director | Board & advisors |
Aidan O'Driscoll | Board Member | Board & advisors |
Complete people profiles for AventaMed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AventaMed
4 dated milestones of AventaMed across 10 years, from founding to its latest funding, stage changes and deals.
- Founded AventaMed is founded.
- Funding First funding round of $124K.
- Funding Latest funding round, Angel Round, of $2.1M.
- Exit Acquired by Karl Storz.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aventamed
Complete news archive for AventaMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AventaMed
AventaMed was founded in 2013 and raised its 1st funding round 1 year after it was founded.
AventaMed is headquartered in Cork, Ireland.
Keith Jansen is the CEO of AventaMed, as recorded in our data. They have also founded this company.
AventaMed is a funded company, having raised a total of $3.58M across 4 funding rounds to date. The company's 1st funding round was a Grant of $123.8K, raised on Nov 2014.
AventaMed is developing surgical devices, initially focused on a device which allows safe placement of ear tubes or grommets in an out-patient setting. Grommets are used to surgically treat Otitis Media with Effusion, which is a build up of fluid behind the ear drum. Was spun out from the MEDIC research centre, Cork Institute of Technology.
AventaMed offers Solo+ ™.
AventaMed has 4 investors. Key investors include Enterprise Ireland, Karl Storz, HBAN, and Irrus Investments.
AventaMed operates through Aventamed Dac.
Yes. AventaMed was acquired by Karl Storz in February 2023.